Cargando…

Pots syndrome: the importance of organic screening in anxiety patients. Case report

INTRODUCTION: 16-year-old female who starts psychiatric follow-up due to episodes of anxiety crises with dizziness and tremors. OBJECTIVES: To expose a case in which it is essential to rule out organic pathology in cases where there is anxiety and physical symptoms. METHODS: Case report and literatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Sol Calderón, P., Mallol Castaño, L., Paricio Del Castillo, R., Izquierdo De La Puente, A., Garcia Moreno, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568072/
http://dx.doi.org/10.1192/j.eurpsy.2022.1206
_version_ 1784809557293268992
author Del Sol Calderón, P.
Mallol Castaño, L.
Paricio Del Castillo, R.
Izquierdo De La Puente, A.
Garcia Moreno, M.
author_facet Del Sol Calderón, P.
Mallol Castaño, L.
Paricio Del Castillo, R.
Izquierdo De La Puente, A.
Garcia Moreno, M.
author_sort Del Sol Calderón, P.
collection PubMed
description INTRODUCTION: 16-year-old female who starts psychiatric follow-up due to episodes of anxiety crises with dizziness and tremors. OBJECTIVES: To expose a case in which it is essential to rule out organic pathology in cases where there is anxiety and physical symptoms. METHODS: Case report and literature review RESULTS: The patient explains that she was in a situation of conflict with her ex-partner, commenting that he did not accept the breakup. Sertraline was prescribed in ascending doses up to 100 mg per day with complete remission of anxiety. 8 months later, she went to the emergency room for loss of consciousness and tremor of the lower limbs. She was diagnosed with conversive disorder and was prescribed lorazepam up to 3 mg per day. Since then, there has been a worsening in the frequency of syncope occurring up to 10 times a day, limiting her academic and social life. She was evaluated by a cardiologist who diagnosed Pots Syndrome (postural orthostatic tachycardia syndrome) and started treatment with ivabradine and mineralocorticoids. With this treatment, the episodes were drastically reduced and spaced out to 1-2 per week. The dose of lorazepam is decreased until its withdrawal without worsening of the anxious symptomatology. CONCLUSIONS: This disorder consists of an involvement of the autonomic nervous system in which there is a sudden drop in blood pressure together with an abrupt increase in heart rate. Its treatment is based on increasing blood volume with drugs such as corticosteroids as well as postural measures with adequate water intake. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9568072
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95680722022-10-17 Pots syndrome: the importance of organic screening in anxiety patients. Case report Del Sol Calderón, P. Mallol Castaño, L. Paricio Del Castillo, R. Izquierdo De La Puente, A. Garcia Moreno, M. Eur Psychiatry Abstract INTRODUCTION: 16-year-old female who starts psychiatric follow-up due to episodes of anxiety crises with dizziness and tremors. OBJECTIVES: To expose a case in which it is essential to rule out organic pathology in cases where there is anxiety and physical symptoms. METHODS: Case report and literature review RESULTS: The patient explains that she was in a situation of conflict with her ex-partner, commenting that he did not accept the breakup. Sertraline was prescribed in ascending doses up to 100 mg per day with complete remission of anxiety. 8 months later, she went to the emergency room for loss of consciousness and tremor of the lower limbs. She was diagnosed with conversive disorder and was prescribed lorazepam up to 3 mg per day. Since then, there has been a worsening in the frequency of syncope occurring up to 10 times a day, limiting her academic and social life. She was evaluated by a cardiologist who diagnosed Pots Syndrome (postural orthostatic tachycardia syndrome) and started treatment with ivabradine and mineralocorticoids. With this treatment, the episodes were drastically reduced and spaced out to 1-2 per week. The dose of lorazepam is decreased until its withdrawal without worsening of the anxious symptomatology. CONCLUSIONS: This disorder consists of an involvement of the autonomic nervous system in which there is a sudden drop in blood pressure together with an abrupt increase in heart rate. Its treatment is based on increasing blood volume with drugs such as corticosteroids as well as postural measures with adequate water intake. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9568072/ http://dx.doi.org/10.1192/j.eurpsy.2022.1206 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Del Sol Calderón, P.
Mallol Castaño, L.
Paricio Del Castillo, R.
Izquierdo De La Puente, A.
Garcia Moreno, M.
Pots syndrome: the importance of organic screening in anxiety patients. Case report
title Pots syndrome: the importance of organic screening in anxiety patients. Case report
title_full Pots syndrome: the importance of organic screening in anxiety patients. Case report
title_fullStr Pots syndrome: the importance of organic screening in anxiety patients. Case report
title_full_unstemmed Pots syndrome: the importance of organic screening in anxiety patients. Case report
title_short Pots syndrome: the importance of organic screening in anxiety patients. Case report
title_sort pots syndrome: the importance of organic screening in anxiety patients. case report
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568072/
http://dx.doi.org/10.1192/j.eurpsy.2022.1206
work_keys_str_mv AT delsolcalderonp potssyndrometheimportanceoforganicscreeninginanxietypatientscasereport
AT mallolcastanol potssyndrometheimportanceoforganicscreeninginanxietypatientscasereport
AT pariciodelcastillor potssyndrometheimportanceoforganicscreeninginanxietypatientscasereport
AT izquierdodelapuentea potssyndrometheimportanceoforganicscreeninginanxietypatientscasereport
AT garciamorenom potssyndrometheimportanceoforganicscreeninginanxietypatientscasereport